Drugs in Pipeline
13
Phase 3 Programs
5
Upcoming Catalysts
5
Next Catalyst
Jan 30, 2026
| Drug Name | Phase |
|---|---|
Docetaxel | Phase 3 |
Adagrasib | Phase 3 |
Nivolumab | Phase 3 |
Pembrolizumab | Phase 3 |
Cetuximab | Phase 3 |
Sitravatinib | Phase 2 |
MGCD0103 | Phase 2 |
Mocetinostat | Phase 2 |
MRTX0902 | Phase 2 |
Adagrasib oral dose of 400 mg twice daily tablets | Phase 2 |
MGCD265 | Phase 2 |
Gemcitabine | Phase 2 |
MRTX849 | Phase 2 |
5 upcoming, 0 past
Primary completion for MRTX849 trial (NCT04793958) in Advanced Colorectal Cancer
SourcePrimary completion for Cetuximab trial (NCT04793958) in Advanced Colorectal Cancer
SourcePrimary completion for Adagrasib oral dose of 400 mg twice daily tablets trial (NCT05609578) in Advanced NSCLC
SourcePrimary completion for MRTX0902 trial (NCT05578092) in Solid Tumor
SourcePrimary completion for Adagrasib trial (NCT05853575) in Advanced Cancer
Source